The burden of disease in pyruvate kinase deficiency: Patients’ perception of the impact on health-related quality of life-Reference-Cited by-同舟云学术

The burden of disease in pyruvate kinase deficiency: Patients’ perception of the impact on health-related quality of life

Published:2018-09-28 Issue:6 Volume:101 Page:758-765
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Grace Rachael F.¹,Cohen Jennifer²,Egan Shayna³⁴^ORCID,Wells Ted³⁴,Witherspoon Brooke³⁴,Ryan Aisling³⁴,Salek Sam S.⁵⁶^ORCID,Bodie Susan⁷,Klaassen Robert J.⁸

Affiliation:

1. Pediatric Hematology/Oncology; Dana-Farber/Boston Children's Cancer and Blood Disorders Center; Boston Massachusetts

2. Patient Advocate; Wrentham Massachusetts

3. Endpoint Outcomes; Boston Massachusetts

4. Endpoint Outcomes; Long Beach California

5. School of Life and Medical Sciences; University of Hertfordshire; Hatfield UK

6. Institute for Medicines Development; Cardiff UK

7. Agios Pharmaceuticals, Inc.; Cambridge Massachusetts

8. Division of Hematology/Oncology; Children's Hospital of Eastern Ontario; Ottawa ON Canada

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.13128/fullpdf

Reference35 articles.

1. Erythrocyte pyruvate kinase deficiency: 2015 status report;Grace;Am J Hematol,2015

2. Selective reticulocyte destruction in erythrocyte pyruvate kinase deficiency;Mentzer;J Clin Invest,1971

3. Hemolytic anemia;Dhaliwal;Am Fam Physician,2004

4. The diagnosis of anemia and its cause;Langley;Can Fam Physician,1984

5. Pyruvate kinase deficiency: the genotype-phenotype association;Zanella;Blood Rev,2007

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnosis and management of pyruvate kinase deficiency: international expert guidelines;The Lancet Haematology;2024-02

2. Real-World Impact of Pyruvate Kinase Deficiency in Children;EMJ Hematology;2023-12-14

3. Psychometric validation of the Pyruvate Kinase Deficiency Diary and Pyruvate Kinase Deficiency Impact Assessment in adults in the phase 3 ACTIVATE trial;Journal of Patient-Reported Outcomes;2023-11-09

4. The Pyruvate Kinase Deficiency Global Longitudinal (Peak) Registry: rationale and study design;BMJ Open;2023-03

5. Pyruvate kinase activator: A major breakthrough in the world of Hematology;Annals of Medicine & Surgery;2022-10